Sergey Ivanovich Glotov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sergey Ivanovich Glotov has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Irina Borisovna Ponomareva
Ryazan State Medical University
12 shared publications - Oleg Mikhaylovich Uryas'Ev
Ryazan State Medical University named after academician I.P. Pavlov
10 shared publications Ryazan State Medical University
4 shared publications- Anna Nikolaevna Ermachkova
Ryazan State Medical University named after academician I.P. Pavlov of the Ministry of Healthcare of Russia
3 shared publications - Lidiya A. Zhukova
Ryazan State Medical University named after academician I.P. Pavlov of the Ministry of Healthcare of the Russian Federation
3 shared publications - Svetlana V. Berstneva
Ryazan State Medical University
3 shared publications
Latest Publications
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (3) , 25-35
Clinical significance of inspiratory capacity and baseline oxygen saturation in the diagnosis of the desaturation phenotype in patients with chronic obstructive pulmonary disease: a cross-sectional diagnostic accuracy study
BACKGROUND: Exercise-induced desaturation in patients with chronic obstructive pulmonary disease (COPD) without marked resting hypoxemia is associated with an unfavorable disease course. However, the value of readily available clinical and functional parameters for identifying this phenotype remains insufficiently studied. AIM: To identify clinical and functional parameters associated with exercise-induced desaturation in patients with COPD, assess their relationship with patients’ functional status, and determine their diagnostic value for identifying the desaturator phenotype. METHODS: This prospective single-center cross-sectional comparative study included 85 men with stable COPD and moderate or severe airflow limitation. Based on the results of the six-minute walk test, 35 patients were classified as desaturators and 50 as non-desaturators. Spirometry, pulse oximetry, and the six-minute walk test with recording of ventilatory parameters were performed. Statistical analysis included nonparametric tests for between-group comparisons, Spearman correlation analysis, binary logistic regression, ROC analysis, and internal five-fold cross-validation. RESULTS: Patients who developed exercise-induced desaturation had more severe dyspnea according to the mMRC (modified Medical Research Council) scale (p = 0.040) and lower values of forced expiratory volume in 1 second (p = 0.004), maximal voluntary ventilation (p = 0.002), end-exercise and minimum breathing reserve (p = 0.003 and p = 0.011, respectively), and baseline and end-exercise inspiratory capacity (p 0.001 and p = 0.003, respectively). Baseline inspiratory capacity correlated with the work performed during the six-minute walk test (ρ = 0.551, p 0.001). The model incorporating baseline SpO₂ and inspiratory capacity yielded an AUC of 0.903 in the complete sample and 0.894 during internal five-fold cross-validation. CONCLUSION: The exercise-induced desaturation phenotype in patients with COPD is primarily associated with impaired respiratory mechanics and gas exchange. Baseline oxygen saturation and inspiratory capacity are clinically relevant parameters for distinguishing between patients with and without exercise-induced desaturation.
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Russian Family Doctor
- Vol. 30 (3) , 25-35
Clinical significance of inspiratory capacity and baseline oxygen saturation in the diagnosis of the desaturation phenotype in patients with chronic obstructive pulmonary disease: a cross-sectional diagnostic accuracy study
BACKGROUND: Exercise-induced desaturation in patients with chronic obstructive pulmonary disease (COPD) without marked resting hypoxemia is associated with an unfavorable disease course. However, the value of readily available clinical and functional parameters for identifying this phenotype remains insufficiently studied. AIM: To identify clinical and functional parameters associated with exercise-induced desaturation in patients with COPD, assess their relationship with patients’ functional status, and determine their diagnostic value for identifying the desaturator phenotype. METHODS: This prospective single-center cross-sectional comparative study included 85 men with stable COPD and moderate or severe airflow limitation. Based on the results of the six-minute walk test, 35 patients were classified as desaturators and 50 as non-desaturators. Spirometry, pulse oximetry, and the six-minute walk test with recording of ventilatory parameters were performed. Statistical analysis included nonparametric tests for between-group comparisons, Spearman correlation analysis, binary logistic regression, ROC analysis, and internal five-fold cross-validation. RESULTS: Patients who developed exercise-induced desaturation had more severe dyspnea according to the mMRC (modified Medical Research Council) scale (p = 0.040) and lower values of forced expiratory volume in 1 second (p = 0.004), maximal voluntary ventilation (p = 0.002), end-exercise and minimum breathing reserve (p = 0.003 and p = 0.011, respectively), and baseline and end-exercise inspiratory capacity (p 0.001 and p = 0.003, respectively). Baseline inspiratory capacity correlated with the work performed during the six-minute walk test (ρ = 0.551, p 0.001). The model incorporating baseline SpO₂ and inspiratory capacity yielded an AUC of 0.903 in the complete sample and 0.894 during internal five-fold cross-validation. CONCLUSION: The exercise-induced desaturation phenotype in patients with COPD is primarily associated with impaired respiratory mechanics and gas exchange. Baseline oxygen saturation and inspiratory capacity are clinically relevant parameters for distinguishing between patients with and without exercise-induced desaturation.
- Open Access
- 14 July 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 9,p. 241-247
Phenotype of the combination of chronic obstructive pulmonary disease and sleep apnea – cross-over syndrome
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are common diseases, and their combination is called overlap syndrome (OS) and is distinguished as a separate phenotype. Physiological disturbances observed during sleep in patients with COPD and OSA include increased upper airway resistance, ineffective gas exchange, and effects on central sleep regulation. Patients with OSA are at higher risk of atrial fibrillation, cardiovascular events, including fatal ones (sudden cardiovascular death), and the risk of developing pulmonary hypertension more often than patients with COPD alone or isolated OSA. The article presents the pathophysiology of respiratory disturbances in patients with OSA during sleep, epidemiological studies, clinical implications, and factors influencing the association of COPD with OSA. It is necessary to use screening questionnaires to identify patients for in-depth diagnostics of OSA, and the clinician should also pay attention to clinical signs defined as indications for the assessment of possible sleep-disordered breathing in COPD. Treatment of OSA in patients with COPD can reduce cardiovascular mortality and improve survival in these patients. Therapy for patients with OS, along with lifestyle changes, includes respiratory support methods: supplemental oxygen therapy, treatment with continuous positive airway pressure (CPAP), non-invasive ventilation (NIV). Bronchodilators and corticosteroids may be appropriate as drugs for drug therapy of SP.
- 14 July 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 9,p. 241-247
Open AccessPhenotype of the combination of chronic obstructive pulmonary disease and sleep apnea – cross-over syndrome
Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) are common diseases, and their combination is called overlap syndrome (OS) and is distinguished as a separate phenotype. Physiological disturbances observed during sleep in patients with COPD and OSA include increased upper airway resistance, ineffective gas exchange, and effects on central sleep regulation. Patients with OSA are at higher risk of atrial fibrillation, cardiovascular events, including fatal ones (sudden cardiovascular death), and the risk of developing pulmonary hypertension more often than patients with COPD alone or isolated OSA. The article presents the pathophysiology of respiratory disturbances in patients with OSA during sleep, epidemiological studies, clinical implications, and factors influencing the association of COPD with OSA. It is necessary to use screening questionnaires to identify patients for in-depth diagnostics of OSA, and the clinician should also pay attention to clinical signs defined as indications for the assessment of possible sleep-disordered breathing in COPD. Treatment of OSA in patients with COPD can reduce cardiovascular mortality and improve survival in these patients. Therapy for patients with OS, along with lifestyle changes, includes respiratory support methods: supplemental oxygen therapy, treatment with continuous positive airway pressure (CPAP), non-invasive ventilation (NIV). Bronchodilators and corticosteroids may be appropriate as drugs for drug therapy of SP.
- Open Access
- 25 September 2025
- Published by ECO-Vector LLC in Russian Family Doctor
- Vol. 29 (3) , 20-28
Continuous respiratory sound monitoring by electronic auscultation: a reliable method for asthma control
BACKGROUND: Asthma is managed using clinical assessment of the patient's condition, questionnaires, and pulmonary function parameters. Respiratory sound monitoring is the most effective way to diagnose and manage nocturnal asthma. There is limited research into respiratory sound monitoring in asthma, and available studies primarily focus on pediatric patients. AIM: This study aimed to assess the reliability of respiratory sound monitoring and changes in the severity of wheezing in patients with various levels of asthma control. METHODS: The study included patients with various levels of asthma control. A Vitalograph ALPHA spirometer (England) was used for spirometry. The author’s technique was used for respiratory sound monitoring by electronic auscultation. The resulting audio files were computer-analyzed. RESULTS: The study included 86 patients, who were divided into groups 1, 2, and 3 with well-controlled, partially controlled, and uncontrolled asthma, respectively. Wheezing episodes had a direct correlation with asthma control level and severity. In group 3, the mean incidence of nocturnal episodes was 3.3 ± 0.4 (p 0.05). Monitoring revealed a strong correlation between the number of wheezing episodes and the level of asthma control (r = 0.74; p 0.05). There was a moderate positive correlation between objective pulmonary function disorders and subjective symptoms (r = 0.39; p 0.05). There was a weak positive correlation between the duration of wheezing episodes and the severity of pulmonary function disorders (r = 0.23; p 0.05). CONCLUSION: Continuous respiratory sound monitoring is a reliable tool for assessing changes in respiratory sounds in patients with asthma.
- 25 September 2025
- Published by ECO-Vector LLC in Russian Family Doctor
- Vol. 29 (3) , 20-28
Open AccessContinuous respiratory sound monitoring by electronic auscultation: a reliable method for asthma control
BACKGROUND: Asthma is managed using clinical assessment of the patient's condition, questionnaires, and pulmonary function parameters. Respiratory sound monitoring is the most effective way to diagnose and manage nocturnal asthma. There is limited research into respiratory sound monitoring in asthma, and available studies primarily focus on pediatric patients. AIM: This study aimed to assess the reliability of respiratory sound monitoring and changes in the severity of wheezing in patients with various levels of asthma control. METHODS: The study included patients with various levels of asthma control. A Vitalograph ALPHA spirometer (England) was used for spirometry. The author’s technique was used for respiratory sound monitoring by electronic auscultation. The resulting audio files were computer-analyzed. RESULTS: The study included 86 patients, who were divided into groups 1, 2, and 3 with well-controlled, partially controlled, and uncontrolled asthma, respectively. Wheezing episodes had a direct correlation with asthma control level and severity. In group 3, the mean incidence of nocturnal episodes was 3.3 ± 0.4 (p 0.05). Monitoring revealed a strong correlation between the number of wheezing episodes and the level of asthma control (r = 0.74; p 0.05). There was a moderate positive correlation between objective pulmonary function disorders and subjective symptoms (r = 0.39; p 0.05). There was a weak positive correlation between the duration of wheezing episodes and the severity of pulmonary function disorders (r = 0.23; p 0.05). CONCLUSION: Continuous respiratory sound monitoring is a reliable tool for assessing changes in respiratory sounds in patients with asthma.
- 31 December 2024
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 12 (4)
Analysis of the Interrelation between Clinical, Laboratory and Radiological Characteristics of Patients with COVID-19 Depending on the Outcome
INTRODUCTION: The clinical picture of COVID-19 has been highly variable since the onset of the pandemic: most patients present with mild symptoms, while others develop severe respiratory failure. It seems relevant to compare subjective and objective manifestations of COVID-19 in hospitalized patients and to evaluate the prognostic significance of clinical, laboratory and radiological characteristics of COVID-19. AIM: To analyze the interrelation between the evidence of subjective and objective data, comorbidity in patients with COVID-19 depending on the outcome of the disease. MATERIALS AND METHODS: The study included 96 patients aged from 25 to 95 years, hospitalized in COVID hospital of City Clinical Emergency Care Hospital of Ryazan from February to May 2022. Patients underwent evaluation of cough and dyspnea intensity on Borg scale, physical examination, laboratory examination, X-ray computed tomography (X-ray CT) of lungs or roentgenography. Depending of the clinical outcome, patients were divided into 2 groups: a group of survivors (68 patients) and a group of deceased (28 patients). Statistical analysis of the data was performed using Statistica 10.0 software package (Stat Soft Inc., USA). RESULTS: The most common complaints on admission were shortness of breath (75%) and general weakness (96.8%). Twenty-four patients indicated absence of dyspnea, while in 19 of them, saturation below 95.0% was recorded. In patients with ‘silent’ dyspnea, X-ray CT revealed statistically significant strong reverse correlation relationships between saturation and lung lesion volume (р < 0.05). Deceased patients had higher subjective evidence of dyspnea and frequency of distant wheezes (р = 0.002 and р < 0.0001, respectively). Overweight, postinfarction cardiosclerosis, chronic heart failure, type 2 diabetes mellitus were more common among deceased patients. Saturation on admission was statistically significantly lower in the group of deceased (р < 0.0001). The first degree of lung damage on X-ray CT was more common in the group of survivors (0.009), the fourth degree of lung damage more commonly occurred in the group of deceased (р = 0.01). In the group of deceased, the hemoglobin level was significantly lower (р = 0,044), and the levels of fibrinogen, lactate dehydrogenase (LDH), urea, glucose, were significantly higher than in the group of survivors. CONCLUSION: When evaluating the severity of the disease in patients with COVID-19, it is necessary to take into account not only the level of laboratory markers, such as LDH, fibrinogen, urea, fasting glycemia, laboratory instrumental test results that evaluate the severity of respiratory failure and spread of the lung tissue damage, but also subjective manifestations of the disease such as higher intensity of dyspnea and distant wheezes. Patients who have reduced saturation with no complaints of dyspnea require increased attention.
- 31 December 2024
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 12 (4)
Analysis of the Interrelation between Clinical, Laboratory and Radiological Characteristics of Patients with COVID-19 Depending on the Outcome
INTRODUCTION: The clinical picture of COVID-19 has been highly variable since the onset of the pandemic: most patients present with mild symptoms, while others develop severe respiratory failure. It seems relevant to compare subjective and objective manifestations of COVID-19 in hospitalized patients and to evaluate the prognostic significance of clinical, laboratory and radiological characteristics of COVID-19. AIM: To analyze the interrelation between the evidence of subjective and objective data, comorbidity in patients with COVID-19 depending on the outcome of the disease. MATERIALS AND METHODS: The study included 96 patients aged from 25 to 95 years, hospitalized in COVID hospital of City Clinical Emergency Care Hospital of Ryazan from February to May 2022. Patients underwent evaluation of cough and dyspnea intensity on Borg scale, physical examination, laboratory examination, X-ray computed tomography (X-ray CT) of lungs or roentgenography. Depending of the clinical outcome, patients were divided into 2 groups: a group of survivors (68 patients) and a group of deceased (28 patients). Statistical analysis of the data was performed using Statistica 10.0 software package (Stat Soft Inc., USA). RESULTS: The most common complaints on admission were shortness of breath (75%) and general weakness (96.8%). Twenty-four patients indicated absence of dyspnea, while in 19 of them, saturation below 95.0% was recorded. In patients with ‘silent’ dyspnea, X-ray CT revealed statistically significant strong reverse correlation relationships between saturation and lung lesion volume (р < 0.05). Deceased patients had higher subjective evidence of dyspnea and frequency of distant wheezes (р = 0.002 and р < 0.0001, respectively). Overweight, postinfarction cardiosclerosis, chronic heart failure, type 2 diabetes mellitus were more common among deceased patients. Saturation on admission was statistically significantly lower in the group of deceased (р < 0.0001). The first degree of lung damage on X-ray CT was more common in the group of survivors (0.009), the fourth degree of lung damage more commonly occurred in the group of deceased (р = 0.01). In the group of deceased, the hemoglobin level was significantly lower (р = 0,044), and the levels of fibrinogen, lactate dehydrogenase (LDH), urea, glucose, were significantly higher than in the group of survivors. CONCLUSION: When evaluating the severity of the disease in patients with COVID-19, it is necessary to take into account not only the level of laboratory markers, such as LDH, fibrinogen, urea, fasting glycemia, laboratory instrumental test results that evaluate the severity of respiratory failure and spread of the lung tissue damage, but also subjective manifestations of the disease such as higher intensity of dyspnea and distant wheezes. Patients who have reduced saturation with no complaints of dyspnea require increased attention.
- Open Access
- 12 December 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (6) , 879-886
“Perplexing” cough
Cough is a serious problem of practical pulmonology. The mechanisms of cough occurrence are diverse and numerous diseases are associated with chronic cough syndrome. The diagnosis can be challenging because of a “perplexing”, “unexplained”, or “idiopathic” cough.The aim of the review was to consider the main underlying mechanisms of the “perplexing” cough, its potential course, an algorithm for managing patients with the persistent cough, and new treatment methods.Conclusion. Chronic “perplexing” cough disrupts the patient’s quality of life and reduces their performance. Unveiling the mechanisms of its development may increase the treatment efficacy.
- 12 December 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (6) , 879-886
Open Access“Perplexing” cough
Cough is a serious problem of practical pulmonology. The mechanisms of cough occurrence are diverse and numerous diseases are associated with chronic cough syndrome. The diagnosis can be challenging because of a “perplexing”, “unexplained”, or “idiopathic” cough.The aim of the review was to consider the main underlying mechanisms of the “perplexing” cough, its potential course, an algorithm for managing patients with the persistent cough, and new treatment methods.Conclusion. Chronic “perplexing” cough disrupts the patient’s quality of life and reduces their performance. Unveiling the mechanisms of its development may increase the treatment efficacy.
- Open Access
- 1 December 2024
- Published by ECO-Vector LLC in Russian Journal of Physiotherapy, Balneology and Rehabilitation
- Vol. 23 (6) , 345-358
The role of pulsed electromagnetic therapy after knee arthroplasty
Background: Pulsed electromagnetic field therapy (PEMF) is included in current clinical guidelines for postoperative rehabilitation after knee arthroplasty. However, its indications remain limited, primarily for managing pain during the early mobilization of the operated joint. Aim: To evaluate pain relief and clinical outcomes — including knee function, general health status, objective and subjective knee swelling assessment, nonsteroidal anti-inflammatory drug (NSAID) consumption, persistent pain, daily activity limitations, and complications — in patients undergoing unicompartmental knee arthroplasty (UKA) followed by PEMF therapy, compared with a control group receiving sham PEMF. Materials and methods: This prospective, randomized, placebo-controlled study included 72 patients who underwent medial UKA. Participants were randomized into either a control group (sham PEMF) or a treatment group receiving PEMF therapy. Patients in the treatment group were advised to use PEMF for 20 minutes, four times daily, for 60 days. Evaluations were conducted preoperatively and at 1, 2, 6, 12, and 36 months postoperatively. The control group followed the same schedule using sham PEMF. Clinical assessments included the Visual Analog Scale (VAS) for pain, the Oxford Knee Score (OKS), the Short Form-36 (SF-36) health survey, a questionnaire on subjective knee swelling, and an objective measurement of knee circumference. NSAID consumption was recorded at each follow-up visit. Results: VAS scores decreased in both groups over time, but statistically significant differences favoring the PEMF group were observed at 6 months (p=0.0143), 12 months (p=0.0004), and 36 months (p=0.0213). One month postoperatively, 73% of patients in the PEMF group and 91% in the control group used NSAIDs (p=0.0341). At 2 months, 14% of the PEMF group continued NSAID use, compared to 38% in the control group (p=0.0326). Objective knee circumference measurements showed statistically significant differences at 6 (p=0.0232), 12 (p=0.0016), and 36 months (p=0.0004), with better outcomes in the PEMF group. Subjective swelling assessment demonstrated statistically significant differences at 2 (p=0.0064), 6 (p=0.0005), 12 (p=0.00022), and 36 months (p=0.00031), again favoring the PEMF group. Finally, OKS scores were significantly higher in the PEMF group across all time points (1 month: p=0.0258; 2 months: p=0.0014; 6 months: p=0.0003; 12 months: p=0.0002; 36 months: p=0.0144). Conclusion: PEMF therapy significantly reduced pain, improved clinical outcomes, and decreased NSAID consumption following medial UKA compared with the control group.
- 1 December 2024
- Published by ECO-Vector LLC in Russian Journal of Physiotherapy, Balneology and Rehabilitation
- Vol. 23 (6) , 345-358
Open AccessThe role of pulsed electromagnetic therapy after knee arthroplasty
Background: Pulsed electromagnetic field therapy (PEMF) is included in current clinical guidelines for postoperative rehabilitation after knee arthroplasty. However, its indications remain limited, primarily for managing pain during the early mobilization of the operated joint. Aim: To evaluate pain relief and clinical outcomes — including knee function, general health status, objective and subjective knee swelling assessment, nonsteroidal anti-inflammatory drug (NSAID) consumption, persistent pain, daily activity limitations, and complications — in patients undergoing unicompartmental knee arthroplasty (UKA) followed by PEMF therapy, compared with a control group receiving sham PEMF. Materials and methods: This prospective, randomized, placebo-controlled study included 72 patients who underwent medial UKA. Participants were randomized into either a control group (sham PEMF) or a treatment group receiving PEMF therapy. Patients in the treatment group were advised to use PEMF for 20 minutes, four times daily, for 60 days. Evaluations were conducted preoperatively and at 1, 2, 6, 12, and 36 months postoperatively. The control group followed the same schedule using sham PEMF. Clinical assessments included the Visual Analog Scale (VAS) for pain, the Oxford Knee Score (OKS), the Short Form-36 (SF-36) health survey, a questionnaire on subjective knee swelling, and an objective measurement of knee circumference. NSAID consumption was recorded at each follow-up visit. Results: VAS scores decreased in both groups over time, but statistically significant differences favoring the PEMF group were observed at 6 months (p=0.0143), 12 months (p=0.0004), and 36 months (p=0.0213). One month postoperatively, 73% of patients in the PEMF group and 91% in the control group used NSAIDs (p=0.0341). At 2 months, 14% of the PEMF group continued NSAID use, compared to 38% in the control group (p=0.0326). Objective knee circumference measurements showed statistically significant differences at 6 (p=0.0232), 12 (p=0.0016), and 36 months (p=0.0004), with better outcomes in the PEMF group. Subjective swelling assessment demonstrated statistically significant differences at 2 (p=0.0064), 6 (p=0.0005), 12 (p=0.00022), and 36 months (p=0.00031), again favoring the PEMF group. Finally, OKS scores were significantly higher in the PEMF group across all time points (1 month: p=0.0258; 2 months: p=0.0014; 6 months: p=0.0003; 12 months: p=0.0002; 36 months: p=0.0144). Conclusion: PEMF therapy significantly reduced pain, improved clinical outcomes, and decreased NSAID consumption following medial UKA compared with the control group.
- 21 November 2024
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 102 (7) , 510–517
Modern view on clinical phenotyping of chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a heterogeneous and multisystem disease with multiple phenotypes and a progressive increase in morbidity and mortality. This article provides a review of the current data on the identification, characterization, and features of therapy for the most common phenotypes of the disease. A literature review was conducted using medical resources such as PubMed, Google Scholar, and UpToDate, addressing issues related to phenotyping in COPD.
- 21 November 2024
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 102 (7) , 510–517
Modern view on clinical phenotyping of chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a heterogeneous and multisystem disease with multiple phenotypes and a progressive increase in morbidity and mortality. This article provides a review of the current data on the identification, characterization, and features of therapy for the most common phenotypes of the disease. A literature review was conducted using medical resources such as PubMed, Google Scholar, and UpToDate, addressing issues related to phenotyping in COPD.
- Open Access
- 11 October 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (5) , 688-699
Intrapulmonary electronic auscultation for asthma and chronic obstructive pulmonary disease
The aim of the study was to develop and perform clinical testing of the intrapulmonary electronic auscultation method for audio and video recording at various levels of the tracheobronchial tree for the diagnosis of asthma and chronic obstructive pulmonary disease (COPD).Methods. We examined 31 patients with moderate (n = 17) and severe (n = 14) COPD with severe symptoms outside of exacerbation and 35 patients with moderate (n = 19) and severe (n = 16) partially controlled asthma. Traditional bronchoscopy was performed, including intrabronchial recording of acoustic noise with a microphone (introduced into the instrumental channel of the bronchoscope) at various levels of the tracheobronchial tree. Video recording in various modes revealed the causes of wheezing. At the same time, pulmonary sounds were recorded in the interscapular region of the chest at the projection points of the bronchoscope in the tracheobronchial tree using a 3M™ Littmann® 3200 electronic stethoscope (USA).Results. The greatest intergroup differences between patients with moderate and severe COPD were demonstrated by intrapulmonary sound parameters (frequency and duration of wheezing, р < 0.0001) and frequency response (amplitude-frequency characteristics) of wheezing in the lumen of the 4th order bronchi (р < 0.0001), significantly exceeded the corresponding sound phenomena during auscultation from the surface of the chest (р < 0.01). The most significant intergroup differences in the groups of BA patients with moderate and severe disease were observed in the frequency response of wheezing during intrapulmonary auscultation in the lumen of the 3rd order (р < 0.0001) and 4th order (р < 0.0001) bronchi; smaller differences were observed in the frequency response during auscultation from the chest surface (р < 0.001).Conclusion. Intrapulmonary auscultation is a modern auscultatory method which can improve the quality and efficiency of diagnosis of asthma and COPD in pulmonology.
- 11 October 2024
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 34 (5) , 688-699
Open AccessIntrapulmonary electronic auscultation for asthma and chronic obstructive pulmonary disease
The aim of the study was to develop and perform clinical testing of the intrapulmonary electronic auscultation method for audio and video recording at various levels of the tracheobronchial tree for the diagnosis of asthma and chronic obstructive pulmonary disease (COPD).Methods. We examined 31 patients with moderate (n = 17) and severe (n = 14) COPD with severe symptoms outside of exacerbation and 35 patients with moderate (n = 19) and severe (n = 16) partially controlled asthma. Traditional bronchoscopy was performed, including intrabronchial recording of acoustic noise with a microphone (introduced into the instrumental channel of the bronchoscope) at various levels of the tracheobronchial tree. Video recording in various modes revealed the causes of wheezing. At the same time, pulmonary sounds were recorded in the interscapular region of the chest at the projection points of the bronchoscope in the tracheobronchial tree using a 3M™ Littmann® 3200 electronic stethoscope (USA).Results. The greatest intergroup differences between patients with moderate and severe COPD were demonstrated by intrapulmonary sound parameters (frequency and duration of wheezing, р < 0.0001) and frequency response (amplitude-frequency characteristics) of wheezing in the lumen of the 4th order bronchi (р < 0.0001), significantly exceeded the corresponding sound phenomena during auscultation from the surface of the chest (р < 0.01). The most significant intergroup differences in the groups of BA patients with moderate and severe disease were observed in the frequency response of wheezing during intrapulmonary auscultation in the lumen of the 3rd order (р < 0.0001) and 4th order (р < 0.0001) bronchi; smaller differences were observed in the frequency response during auscultation from the chest surface (р < 0.001).Conclusion. Intrapulmonary auscultation is a modern auscultatory method which can improve the quality and efficiency of diagnosis of asthma and COPD in pulmonology.
- 7 April 2024
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 32 (1) , 145-158
Pathogenetic Aspects of Bronchial Asthma Phenotyping
INTRODUCTION: During a many-year history of its study, bronchial asthma (BA) has gone through the stages of numerous classifications. The introduction of specific biological therapy of BA permitted to speak about the phenotypes of the disease. AIM: Presentation of the main pathophysiological mechanisms for isolation of endotypes and phenotypes of BA. The diagnosis of phenotype of BA is based on the pathophysiological mechanisms of its development, which permit to evaluate the dynamics of the disease, make the diagnosis and predict the course of the disease. The most complicated aspect of BA phenotyping is severe forms of the disease characterized by a combination of different phenotypes. This impedes evaluation of specific pathogenetic mechanisms and administration of the optimal therapy for the patient. CONCLUSION: The diagnosis of BA phenotypes permits to identify specific pathogenetic mechanisms and thereby personalize the treatment.
- 7 April 2024
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 32 (1) , 145-158
Pathogenetic Aspects of Bronchial Asthma Phenotyping
INTRODUCTION: During a many-year history of its study, bronchial asthma (BA) has gone through the stages of numerous classifications. The introduction of specific biological therapy of BA permitted to speak about the phenotypes of the disease. AIM: Presentation of the main pathophysiological mechanisms for isolation of endotypes and phenotypes of BA. The diagnosis of phenotype of BA is based on the pathophysiological mechanisms of its development, which permit to evaluate the dynamics of the disease, make the diagnosis and predict the course of the disease. The most complicated aspect of BA phenotyping is severe forms of the disease characterized by a combination of different phenotypes. This impedes evaluation of specific pathogenetic mechanisms and administration of the optimal therapy for the patient. CONCLUSION: The diagnosis of BA phenotypes permits to identify specific pathogenetic mechanisms and thereby personalize the treatment.
- 29 March 2024
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 1
CHRONIC OBSTRUCTIVE PULMONARY DISEASE: RATE OF THERAPIOTIC ADHERENCE IN OUTPATIENT PRACTICE
The adherence of a patient with chronic obstructive pulmonary disease (COPD) to treatment is of utmost importance as it prevents the disease progression and the delayed complication development that determine the quality of life and life span. The purpose of the study is to assess the level of adherence for patients with COPD to drug therapy with respiratory drugs, to identify factors influencing the adherence, and study 5-year survival rate based on adherence level. Materials and Methods. The study enrolled 150 patients with COPD (87 men, and 63 women, mean age 58.3±0.86 years). Pulmonary function (FEV1, FVC, FEV1/FVC), severity of respiratory symptoms (mMRS scale, CAT questionnaire), and disease severity were assessed (GOLD, 2022). Adherence to COPD treatment was determined according to the Morisky-Green test (1986). Five-year survival rate of patients was analyzed. Results. Low adherence to treatment in patients with COPD was revealed: 1 month after the initiation or correction of respiratory therapy, only 32 patients (21.3 %) were assessed as adherent, 56 patients (37.3 %) were insufficiently adherent, and 62 patients (41.3 %) were non-adherent to treatment. Adherence to treatment was associated with age, disease severity, severity of respiratory symptoms, FEV1 and did not depend on gender. In five years, survival rate in the group of non-adherent patients (89.5 %) and insufficiently adherent patients (80.4 %) was significantly higher than in the group of adherent one (61.9 %). It is associated with a more severe status of patients who are adherent to therapy. Conclusion. The authors identified an insufficient adherence level in patients with COPD. Elderly patients with a more severe course of the disease, low FEV1 levels, and severe exacerbations are more adherent to respiratory drug therapy. Worse five-year survival rates were observed in the group of patients who were adherent to therapy. It was associated with more severe clinical status, age and comorbidity.
- 29 March 2024
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 1
CHRONIC OBSTRUCTIVE PULMONARY DISEASE: RATE OF THERAPIOTIC ADHERENCE IN OUTPATIENT PRACTICE
The adherence of a patient with chronic obstructive pulmonary disease (COPD) to treatment is of utmost importance as it prevents the disease progression and the delayed complication development that determine the quality of life and life span. The purpose of the study is to assess the level of adherence for patients with COPD to drug therapy with respiratory drugs, to identify factors influencing the adherence, and study 5-year survival rate based on adherence level. Materials and Methods. The study enrolled 150 patients with COPD (87 men, and 63 women, mean age 58.3±0.86 years). Pulmonary function (FEV1, FVC, FEV1/FVC), severity of respiratory symptoms (mMRS scale, CAT questionnaire), and disease severity were assessed (GOLD, 2022). Adherence to COPD treatment was determined according to the Morisky-Green test (1986). Five-year survival rate of patients was analyzed. Results. Low adherence to treatment in patients with COPD was revealed: 1 month after the initiation or correction of respiratory therapy, only 32 patients (21.3 %) were assessed as adherent, 56 patients (37.3 %) were insufficiently adherent, and 62 patients (41.3 %) were non-adherent to treatment. Adherence to treatment was associated with age, disease severity, severity of respiratory symptoms, FEV1 and did not depend on gender. In five years, survival rate in the group of non-adherent patients (89.5 %) and insufficiently adherent patients (80.4 %) was significantly higher than in the group of adherent one (61.9 %). It is associated with a more severe status of patients who are adherent to therapy. Conclusion. The authors identified an insufficient adherence level in patients with COPD. Elderly patients with a more severe course of the disease, low FEV1 levels, and severe exacerbations are more adherent to respiratory drug therapy. Worse five-year survival rates were observed in the group of patients who were adherent to therapy. It was associated with more severe clinical status, age and comorbidity.